Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for Exercise Capacity in Cardiac Allograft Vasculopathy After Heart Transplantation
2016-004706-33Phase 4Terminated
- Sponsor
- Finn Gustafsson
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary vasculopathy and cardiac morbidity comparing Ivabradine with Placebo (2 arms). Primary endpoint: Change in VO2max. Started Feb 2017; status: terminated.
02
Drugs
ivabradine
03
Conditions
coronary vasculopathycardiac morbidity
Beyond the preview
Go deeper on 2016-004706-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004706-33.